FDA Permits Marketing of First COVID-19 At-Home Test Using Traditional Premarket Review Process

SILVER SPRING, Md., June 6, 2023 /PRNewswire/ — Today, the U.S. Food and Drug Administration granted marketing authorization for the Cue COVID-19 Molecular Test. The product is a molecular nucleic acid amplification test (NAAT) that is intended to detect genetic material from SARS-CoV-2 virus…

Source: www.prnewswire.com – Read more